What parents should know about GLP-1s for kids
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
39 trends tracked about this subject — the full history, oldest to newest below.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Current reporting examines how GLP-1 medications are shifting cultural perceptions surrounding body image.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.
McDonald's announces massive investments in menu updates, artificial intelligence, and PlayPlaces amid rising customer cost concerns.
Medical and lifestyle experts are questioning the long-term safety and efficacy of GLP-1 medications as they transition from clinical tools to consumer drugs.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New research indicates nearly 17% of children using GLP-1 receptor agonists developed nutritional deficiencies within one year of treatment.
New reports warn that discontinuing GLP-1 weight-loss medications like Ozempic, Mounjaro, and Wegovy may increase the risk of heart attack and stroke.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
As GLP-1 use rises among millions of parents and an increasing number of children, new medical data warns of nutritional risks for youth.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Recent reporting examines the widespread prescribing of GLP-1 medications and their broad societal and biological impacts.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Insurance executives and employers are redefining access to GLP-1 weight-loss medications amid shifting coverage trends and affordability challenges.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Social media discourse and emerging clinical research are converging on the long-term potential of GLP-1 agonists beyond weight management.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Serena Williams' Queen’s comeback ends abruptly as injury to her doubles partner reshapes her return narrative